A dosimetry trial of uPAR targeted radioligand therapy in patients with glioblastoma

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-520105-39-00

Acronym

64Cu-DOTA-AE105-201

Enrollment

Registered

2025-08-22

Start date

2025-11-25

Completion date

Unknown

Last updated

2025-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioblastoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Denmark

None listed

Source: EU CTIS · Data processed: Feb 4, 2026